Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedA newer site revision tag, Revision: v3.5.4, has been added, replacing the previous v3.5.3. This reflects a minor site release or update to the page’s metadata rather than a substantive change to content visible to users.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer revision was updated from **v3.5.2** to **v3.5.3**, reflecting a site release/version change rather than any change to the clinical trial’s content.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated to version 3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated the page revision to v3.5.0; the previous revision entry v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 was added, and the previous notices (including the funding-lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.